Month: June 2020
Amneal Pharmaceuticals Recalls Metformin ER for Carcinogens
Another drug-maker has recalled extended-release metformin due to high levels of a cancer-causing chemical called NDMA.
Apotex Corp. Recalls Extended-Release Metformin for Carcinogens
Apotex Corp. recalled all lots of extended-release metformin (500-mg) after FDA tests found high levels of a cancer-causing chemical.